Markey Cancer Center

Screen%20Shot%202018-11-19%20at%201.09.43%20PM.png

New NCI Grant Expands Markey’s Successful Oncology Training Program to High Schoolers

Nov 26, 2018, 8:51 AM

After successfully launching an oncology training program for Appalachian undergrads in 2016, the University of Kentucky Markey Cancer Center is expanding the program to include high school students.

UK Study Finds Promising Therapeutic Target for Aggressive Type of Breast Cancer

Nov 12, 2018, 9:31 AM

A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer.

20170412%20-%20Ren%20Xu%20COBRE%20Photos%20-%20A7R%20-%20002.JPG

A Promise We Intend to Keep

Nov 6, 2018, 8:30 AM

Kentucky faces the highest cancer incidence and mortality rates in the United States. Researchers at the University of Kentucky aim to reduce these numbers by half. We believe that’s what Kentucky can do.

Study: Ultrasound Ovarian Cancer Screening Improves Survival

Nov 1, 2018, 9:37 AM

A University of Kentucky study just published in Obstetrics & Gynecology shows that annual ultrasound screening of at-risk asymptomatic women increases the survival rates of women with type I and type II epithelial ovarian cancer.

Markey Hits Major Milestone for Personalized Medicine Consortium

Nov 1, 2018, 9:02 AM

Just one year after joining the Oncology Research Information Exchange Network (ORIEN), the University of Kentucky Markey Cancer Center has already enrolled more than 1,000 patients. ORIEN is an alliance of 19 major cancer centers that shares information to allow its members to push forward evidence-based cancer care to patients.

New Markey study shows promise for targeting breast cancer metastasis

Oct 8, 2018, 8:55 AM

A study through the UK Markey Cancer Center shows promise for targeting breast cancer metastasis. Metastasis causes 90 percent of breast cancer-related deaths.

Markey%20Cancer%20Center%20building_0.JPG

To Fight Kentucky’s Biggest Cancer Killer, Markey Researchers Think Small

Sep 26, 2018, 10:23 AM

In a study published in the Journal of Controlled Release, University of Kentucky Markey Cancer Center researchers used nanoparticles to deliver powerful chemotherapy drugs directly to lungs affected by metastatic disease while avoiding toxicity elsewhere in the body.

Subscribe to Markey Cancer Center